Suppr超能文献

IP-10和LAM抗原水平在高负担环境下对结核性胸腔积液诊断的临床诊断效用

Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting.

作者信息

Dheda Keertan, Van-Zyl Smit Richard N, Sechi Leonardo A, Badri Motasim, Meldau Richard, Symons Gregory, Khalfey Hoosein, Carr Igshaan, Maredza Alice, Dawson Rodney, Wainright Helen, Whitelaw Andrew, Bateman Eric D, Zumla Alimuddin

机构信息

Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

出版信息

PLoS One. 2009;4(3):e4689. doi: 10.1371/journal.pone.0004689. Epub 2009 Mar 11.

Abstract

BACKGROUND

Current tools for the diagnosis of tuberculosis pleural effusions are sub-optimal. Data about the value of new diagnostic technologies are limited, particularly, in high burden settings. Preliminary case control studies have identified IFN-gamma-inducible-10 kDa protein (IP-10) as a promising diagnostic marker; however, its diagnostic utility in a day-to-day clinical setting is unclear. Detection of LAM antigen has not previously been evaluated in pleural fluid.

METHODS

We investigated the comparative diagnostic utility of established (adenosine deaminase [ADA]), more recent (standardized nucleic-acid-amplification-test [NAAT]) and newer technologies (a standardized LAM mycobacterial antigen-detection assay and IP-10 levels) for the evaluation of pleural effusions in 78 consecutively recruited South African tuberculosis suspects. All consenting participants underwent pleural biopsy unless contra-indicated or refused. The reference standard comprised culture positivity for M. tuberculosis or histology suggestive of tuberculosis.

PRINCIPAL FINDINGS

Of 74 evaluable subjects 48, 7 and 19 had definite, probable and non-TB, respectively. IP-10 levels were significantly higher in TB vs non-TB participants (p<0.0001). The respective outcomes [sensitivity, specificity, PPV, NPV %] for the different diagnostic modalities were: ADA at the 30 IU/L cut-point [96; 69; 90; 85], NAAT [6; 93; 67; 28], IP-10 at the 28,170 pg/ml ROC-derived cut-point [80; 82; 91; 64], and IP-10 at the 4035 pg/ml cut-point [100; 53; 83; 100]. Thus IP-10, using the ROC-derived cut-point, missed approximately 20% of TB cases and mis-diagnosed approximately 20% of non-TB cases. By contrast, when a lower cut-point was used a negative test excluded TB. The NAAT had a poor sensitivity but high specificity. LAM antigen-detection was not diagnostically useful.

CONCLUSION

Although IP-10, like ADA, has sub-optimal specificity, it may be a clinically useful rule-out test for tuberculous pleural effusions. Larger multi-centric studies are now required to confirm our findings.

摘要

背景

目前用于诊断结核性胸腔积液的工具并不理想。关于新诊断技术价值的数据有限,尤其是在高负担地区。初步病例对照研究已将γ-干扰素诱导10 kDa蛋白(IP-10)鉴定为一种有前景的诊断标志物;然而,其在日常临床环境中的诊断效用尚不清楚。此前尚未在胸腔积液中评估LAM抗原的检测。

方法

我们调查了已确立的(腺苷脱氨酶[ADA])、较新的(标准化核酸扩增检测[NAAT])和更新的技术(标准化LAM分枝杆菌抗原检测试验和IP-10水平)对78例连续招募的南非结核病疑似患者胸腔积液评估的比较诊断效用。所有同意的参与者均接受胸腔活检,除非有禁忌或拒绝。参考标准包括结核分枝杆菌培养阳性或提示结核病的组织学检查。

主要发现

在74例可评估的受试者中,48例、7例和19例分别患有确诊、可能和非结核性疾病。结核病患者的IP-10水平显著高于非结核病参与者(p<0.0001)。不同诊断方法的各自结果[敏感性、特异性、阳性预测值、阴性预测值%]为:ADA在30 IU/L切点时[96;69;90;85],NAAT[6;93;67;28],IP-10在28170 pg/ml ROC得出的切点时[80;82;91;64],以及IP-10在4035 pg/ml切点时[100;53;83;100]。因此,使用ROC得出的切点时,IP-10漏诊了约20%的结核病例,误诊了约20%的非结核病例。相比之下,使用较低切点时,阴性检测可排除结核病。NAAT敏感性差但特异性高。LAM抗原检测在诊断上无用处。

结论

尽管IP-10与ADA一样,特异性并不理想,但它可能是一种对结核性胸腔积液有用的临床排除试验。现在需要更大规模的多中心研究来证实我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/2650091/f7cf6eb63d18/pone.0004689.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验